Retatrutide is a synthetic peptide that binds the GIP, GLP-1 and glucagon receptors in in-vitro receptor assays. Its structure and receptor pharmacology are described in the published literature and in laboratory binding studies.
Retatrutide is not approved by the FDA and is supplied for laboratory research only. Refer to the primary published literature for details.
Structure, assay and handling notes for laboratory work
Retatrutide is a synthetic peptide built as a single chain of amino acids with a lipid-type side group attached to extend its stability in solution. In the laboratory it is studied as a triple agonist, meaning it is designed to engage the GIP, GLP-1 and glucagon receptors in cell-based receptor assays. Because it is a long, modified peptide, characterising it takes more than one measurement.
How a sample is characterised
A typical analytical package combines two techniques. HPLC separates the sample and gives a purity figure based on the main peak. LC-MS then compares the measured molecular mass with the expected mass, which helps confirm identity. Our guide to HPLC vs LC-MS explains the difference. Some laboratories also report endotoxin, which matters for cell-based work.
Check the certificate
The published certificate for Retatrutide 15 comes from Janoshik and is listed in the COA library with its batch number. Match that batch number to your own vial. A certificate describes the batch it names, so a different batch or strength needs its own record. Retatrutide 30 does not currently have a published certificate.
Laboratory handling
Lyophilized material should stay sealed and dry. Store refrigerated. Use clean, dry consumables, label vials with the date opened and keep notes of the batch you used so results can be traced back. For laboratory research use only.
Our retatrutide is supplied for laboratory research use only to qualified research professionals. A certificate of analysis for one of the two retatrutide listings is published in our COA library; one for the other listing is not yet published.
Third-party test results, where available, are published in our COA library: https://mindfulpeptides.com/coas/
